Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01772472 |
|---|---|
| Brief Title: | A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE) |
| First Submitted : | January 17, 2013 |
| First Submitted that Met QC Criteria : | January 17, 2013 |
| First Posted : | January 21, 2013 (Estimate) |
| Results First Submitted : | July 24, 2019 |
| Results First Submitted that Met QC Criteria : | September 9, 2019 |
| Results First Posted : | October 1, 2019 |
| Last Update Submitted that Met QC Criteria : | April 30, 2024 |
| Last Update Posted : | May 2, 2024 |